| Primary |
| Product Used For Unknown Indication |
29.3% |
| Tuberculosis |
12.0% |
| Mycobacterium Abscessus Infection |
9.8% |
| Mycobacterium Avium Complex Infection |
7.6% |
| Urinary Tract Infection |
5.4% |
| Antiviral Treatment |
4.3% |
| Infection |
4.3% |
| Pulmonary Tuberculosis |
4.3% |
| Acute Myeloid Leukaemia |
3.3% |
| Endophthalmitis |
3.3% |
| Cystic Fibrosis |
2.2% |
| Gout |
2.2% |
| Pain In Extremity |
2.2% |
| Pneumonia Aspiration |
2.2% |
| Urinary Tract Infection Staphylococcal |
2.2% |
| Analgesic Therapy |
1.1% |
| Anxiety |
1.1% |
| Arthritis Bacterial |
1.1% |
| Bacteraemia |
1.1% |
| Candidiasis |
1.1% |
|
| Deafness |
15.2% |
| Stevens-johnson Syndrome |
12.1% |
| Pancytopenia |
9.1% |
| Medication Error |
6.1% |
| Ototoxicity |
6.1% |
| Renal Failure Acute |
6.1% |
| Tinnitus |
6.1% |
| Blood Creatinine Increased |
3.0% |
| Clostridium Difficile Colitis |
3.0% |
| Deafness Unilateral |
3.0% |
| Dizziness |
3.0% |
| Drug Administration Error |
3.0% |
| Drug Prescribing Error |
3.0% |
| Dyspnoea |
3.0% |
| Incorrect Route Of Drug Administration |
3.0% |
| Meningitis |
3.0% |
| Mycobacterium Abscessus Infection |
3.0% |
| Neutropenia |
3.0% |
| Obstructive Airways Disorder |
3.0% |
| Rash Macular |
3.0% |
|
| Secondary |
| Product Used For Unknown Indication |
23.7% |
| Drug Use For Unknown Indication |
9.5% |
| Tuberculosis |
7.5% |
| Pneumonia |
6.9% |
| Pyrexia |
6.3% |
| Bacteraemia |
5.6% |
| Hypertension |
4.8% |
| Infection |
4.4% |
| Mycobacterium Avium Complex Infection |
4.3% |
| Sepsis |
3.5% |
| Antibiotic Prophylaxis |
3.0% |
| Febrile Neutropenia |
2.8% |
| Drug Exposure During Pregnancy |
2.7% |
| Mycobacterium Abscessus Infection |
2.7% |
| Type 2 Diabetes Mellitus |
2.4% |
| Antibiotic Therapy |
2.2% |
| Hiv Infection |
2.2% |
| Pseudomonas Infection |
2.0% |
| Prophylaxis |
1.9% |
| Bronchopulmonary Aspergillosis |
1.8% |
|
| Thrombocytopenia |
11.0% |
| Toxic Epidermal Necrolysis |
11.0% |
| Renal Failure Acute |
9.0% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
8.2% |
| Renal Failure |
6.5% |
| Acute Generalised Exanthematous Pustulosis |
5.7% |
| Toxic Skin Eruption |
5.7% |
| Hypoacusis |
4.5% |
| Skin Exfoliation |
4.5% |
| Pancytopenia |
3.7% |
| Toxicity To Various Agents |
3.7% |
| Photosensitivity Reaction |
3.3% |
| Septic Shock |
3.3% |
| Vomiting |
3.3% |
| Infection |
2.9% |
| Pneumonia |
2.9% |
| Premature Baby |
2.9% |
| Renal Tubular Disorder |
2.9% |
| Stevens-johnson Syndrome |
2.9% |
| Cholestasis |
2.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
22.9% |
| Product Used For Unknown Indication |
19.4% |
| Pyrexia |
6.6% |
| Tuberculosis |
5.6% |
| Acute Lymphocytic Leukaemia |
5.4% |
| Prophylaxis |
5.1% |
| Infection |
3.5% |
| Acute Myeloid Leukaemia |
3.1% |
| Pulmonary Tuberculosis |
3.1% |
| Hiv Infection |
3.0% |
| Pneumonia |
2.9% |
| Diffuse Large B-cell Lymphoma |
2.6% |
| Febrile Neutropenia |
2.4% |
| Hypertension |
2.3% |
| Sepsis |
2.3% |
| Pain |
2.2% |
| Antibiotic Prophylaxis |
2.2% |
| Sedation |
2.1% |
| Mycobacterium Avium Complex Infection |
1.8% |
| Anaesthesia |
1.6% |
|
| Septic Shock |
12.3% |
| Sepsis |
11.0% |
| Vomiting |
11.0% |
| Thrombocytopenia |
8.5% |
| Drug Ineffective |
6.3% |
| White Blood Cell Count Decreased |
6.0% |
| Renal Failure Acute |
5.8% |
| Arrhythmia |
4.5% |
| Pyrexia |
4.5% |
| Pneumonia |
4.0% |
| Bradycardia |
3.6% |
| Toxic Epidermal Necrolysis |
3.1% |
| Transaminases Increased |
2.9% |
| Febrile Neutropenia |
2.7% |
| Respiratory Arrest |
2.5% |
| Sudden Death |
2.5% |
| White Blood Cell Count Increased |
2.5% |
| Neutropenia |
2.2% |
| Tachycardia |
2.2% |
| Respiratory Failure |
2.0% |
|
| Interacting |
| Infection Prophylaxis |
25.0% |
| Osteitis |
25.0% |
| Pneumonia |
25.0% |
| Bacteraemia |
8.3% |
| Prophylaxis Against Graft Versus Host Disease |
8.3% |
| Sepsis |
8.3% |
|
| International Normalised Ratio Increased |
18.2% |
| Overdose |
18.2% |
| Renal Impairment |
18.2% |
| Thrombocytopenia |
18.2% |
| Drug Interaction |
9.1% |
| Renal Failure Acute |
9.1% |
| Sepsis |
9.1% |
|
